FLAURA2 results demonstrate osimertinib plus chemotherapy superior compared to osimertinib alone
Osimertinib plus chemotherapy demonstrated a statistically significant and clinically meaningful progression-free survival benefit compared to osimertinib alone, according to research presented at the International Association ...
Sep 11, 2023
0
7